Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.

Correa DD, Rocco-Donovan M, DeAngelis LM, Dolgoff-Kaspar R, Iwamoto F, Yahalom J, Abrey LE.

J Neurooncol. 2009 Feb;91(3):315-21. doi: 10.1007/s11060-008-9716-0. Epub 2008 Nov 1.

PMID:
18974934
2.

Cognitive functions in survivors of primary central nervous system lymphoma.

Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE.

Neurology. 2004 Feb 24;62(4):548-55.

PMID:
14981169
3.

Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Correa DD, Shi W, Abrey LE, Deangelis LM, Omuro AM, Deutsch MB, Thaler HT.

Neuro Oncol. 2012 Jan;14(1):101-8. doi: 10.1093/neuonc/nor186. Epub 2011 Oct 19.

4.

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.

Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dósa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick N, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA.

Neurology. 2013 Jul 2;81(1):84-92. doi: 10.1212/WNL.0b013e318297eeba. Epub 2013 May 17.

5.

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.

Cheng T, Forsyth P, Chaudhry A, Morris D, Glück S, Russell JA, Stewart DA.

Bone Marrow Transplant. 2003 Apr;31(8):679-85.

PMID:
12692608
6.

Cognitive status and quality of life after treatment for primary CNS lymphoma.

Harder H, Holtel H, Bromberg JE, Poortmans P, Haaxma-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ.

Neurology. 2004 Feb 24;62(4):544-7.

PMID:
14981168
7.

Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.

Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ.

Lancet Neurol. 2009 Sep;8(9):810-8. doi: 10.1016/S1474-4422(09)70204-2. Epub 2009 Aug 7.

PMID:
19665931
8.

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

Shah GD, Yahalom J, Correa DD, Lai RK, Raizer JJ, Schiff D, LaRocca R, Grant B, DeAngelis LM, Abrey LE.

J Clin Oncol. 2007 Oct 20;25(30):4730-5. Erratum in: J Clin Oncol. 2008 Jan 10;26(2):340.

PMID:
17947720
9.

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA.

Lancet Oncol. 2009 Nov;10(11):1037-44. doi: 10.1016/S1470-2045(09)70263-3. Epub 2009 Oct 2.

PMID:
19801201
10.

Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.

Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U.

Neurology. 2005 Apr 12;64(7):1184-8.

PMID:
15824344
11.

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.

J Clin Oncol. 2006 Aug 20;24(24):3865-70. Epub 2006 Jul 24.

PMID:
16864853
12.

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

Thiel E, Korfel A, Martus P, Kanz L, Griesinger F, Rauch M, Röth A, Hertenstein B, von Toll T, Hundsberger T, Mergenthaler HG, Leithäuser M, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Plasswilm L, Nägele T, Pietsch T, Bamberg M, Weller M.

Lancet Oncol. 2010 Nov;11(11):1036-47. doi: 10.1016/S1470-2045(10)70229-1. Epub 2010 Oct 20.

PMID:
20970380
13.

Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.

Hilverda K, Bosma I, Heimans JJ, Postma TJ, Peter Vandertop W, Slotman BJ, Buter J, Reijneveld JC, Klein M.

J Neurooncol. 2010 Mar;97(1):89-94. doi: 10.1007/s11060-009-9993-2. Epub 2009 Aug 30.

14.

Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.

Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T.

Strahlenther Onkol. 2003 Sep;179(9):626-32.

PMID:
14628129
15.

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.

Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A.

J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7.

PMID:
24101038
16.

Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines.

Correa DD, Maron L, Harder H, Klein M, Armstrong CL, Calabrese P, Bromberg JE, Abrey LE, Batchelor TT, Schiff D.

Ann Oncol. 2007 Jul;18(7):1145-51. Epub 2007 Feb 6. Review.

PMID:
17284616
17.

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Korfel A, Thiel E, Martus P, Möhle R, Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T, Hundsberger T, Mergenthaler HG, Junghanß C, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Roth P, Bamberg M, Pietsch T, Weller M.

Neurology. 2015 Mar 24;84(12):1242-8. doi: 10.1212/WNL.0000000000001395. Epub 2015 Feb 25.

PMID:
25716362
18.

Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?

Omuro A, Taillandier L, Chinot O, Sierra Del Rio M, Carnin C, Barrie M, Soussain C, Tanguy ML, Choquet S, Leblond V, Hoang-Xuan K; ANOCEF Group (French Neuro-Oncology Association)..

J Neurooncol. 2011 Aug;104(1):323-30. doi: 10.1007/s11060-010-0497-x. Epub 2010 Dec 19.

PMID:
21170569
19.

Neuropsychological functioning of children treated for acute lymphoblastic leukemia: impact of whole brain radiation therapy.

Annett RD, Hile S, Bedrick E, Kunin-Batson AS, Krull KR, Embry L, MacLean WE Jr, Noll RB.

Psychooncology. 2015 Feb;24(2):181-9. doi: 10.1002/pon.3586. Epub 2014 Jun 2.

PMID:
24890730
20.

Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.

Ichikawa T, Kurozumi K, Michiue H, Ishida J, Maeda Y, Kondo E, Kawasaki A, Date I.

Clin Neurol Neurosurg. 2014 Dec;127:106-11. doi: 10.1016/j.clineuro.2014.10.011. Epub 2014 Oct 22.

PMID:
25459253

Supplemental Content

Support Center